ストックスクリーナーアプリを入手
0.87
16.08%
0.1205
前日終値:
$0.7495
開ける：
$0.7761
24時間の取引高:
933.84K
Relative Volume:
0.55
時価総額：
$5.10M
収益：
$4.70M
当期純損益:
$-4.99M
株価収益率:
-0.1355
EPS:
-6.42
ネットキャッシュフロー:
$-5.29M
1週間 パフォーマンス:
-27.50%
1か月 パフォーマンス:
-76.98%
6か月 パフォーマンス:
-92.57%
1年 パフォーマンス:
-96.03%
1日の値動き範囲:
$0.75
$0.87
1週間の範囲:
$0.7106
$1.14
52週間の値動き範囲:
$0.7106
$108.00
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
名前
Salarius Pharmaceuticals Inc
セクター
電話
346-772-0346
住所
2450 HOLCOMBE BLVD, HOUSTON
SLRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
0.87 | 4.39M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-04-27 | 開始されました | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc (SLRX) 最新ニュース
Salarius Pharmaceuticals Inc. (SLRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
SLRX Stock Institutional Owners - Quiver Quantitative
How Salarius Pharmaceuticals Inc. stock reacts to inflationary pressuresJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - newser.com
Salarius Pharmaceuticals Exec VP Finance, CFO Mark J Rosenblum Acquires 20,000 Shares - TradingView
[Form 4] Salarius Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Why Salarius Pharmaceuticals Inc. (FP10) stock stays resilientJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - newser.com
Will Salarius Pharmaceuticals Inc. (FP10) stock benefit from infrastructure bill - newser.com
How Salarius Pharmaceuticals Inc. (FP10) stock responds to job market shifts2025 Breakouts & Breakdowns & Safe Entry Zone Identification - newser.com
Ranking Salarius Pharmaceuticals Inc. among high performing stocks via toolsProduct Launch & Stepwise Entry/Exit Trade Alerts - newser.com
When is the best time to exit Salarius Pharmaceuticals Inc.Market Trend Summary & Free Weekly Watchlist of Top Performers - newser.com
What catalysts could drive Salarius Pharmaceuticals Inc. stock higher - newser.com
Applying Elliott Wave Theory to Salarius Pharmaceuticals Inc.Portfolio Profit Report & Low Risk Profit Maximizing Plans - newser.com
Salarius clarifies Nasdaq listing status, refutes S&P CapIQ error By Investing.com - Investing.com Australia
[8-K] Salarius Pharmaceuticals, Inc. Reports Material Event | SLRX SEC FilingForm 8-K - Stock Titan
Salarius Pharmaceuticals Says S&P Capital IQ Platform Misreported Nasdaq Status After Merger - MarketScreener
Salarius Pharmaceuticals (SLRX) Maintains Nasdaq Listing Despite Reporting Error - GuruFocus
Trend analysis for Salarius Pharmaceuticals Inc. this weekWeekly Risk Report & Advanced Swing Trade Entry Plans - newser.com
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol 'SLRX” - The Manila Times
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX” - GlobeNewswire
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger With Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol "SLRX" - 富途牛牛
Intraday pattern recognizer results for Salarius Pharmaceuticals Inc.Market Weekly Review & Verified Swing Trading Watchlist - newser.com
Ewing Sarcoma Market Research Report 2025-2035: Salarius, Eli Lilly, Pfizer, and BioAtla Lead by Driving Innovations in the Development of Novel Targeted Therapies - Yahoo Finance UK
Will Salarius Pharmaceuticals Inc. (FP10) stock keep raising dividendsOil Prices & Verified Swing Trading Watchlist - newser.com
Will Salarius Pharmaceuticals Inc. (FP10) stock benefit from Fed rate cutsQuarterly Profit Report & Daily Market Momentum Tracking - newser.com
Technical analysis overview for Salarius Pharmaceuticals Inc. stock2025 Price Momentum & Target Return Focused Stock Picks - newser.com
Historical volatility pattern of Salarius Pharmaceuticals Inc. visualizedCEO Change & Verified Short-Term Plans - newser.com
Is now a turning point for Salarius Pharmaceuticals Inc.Quarterly Portfolio Review & Low Volatility Stock Suggestions - newser.com
Salarius Pharmaceuticals Announces New Executive Appointments - MSN
Salarius Pharmaceuticals Inc (SLRX) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):